Home › Funds › BRAIDWELL LP › ORKA

BRAIDWELL LP position in ORKA

ORUKA THERAPEUTICS INC · Health Care

BRAIDWELL LP reported holding 278,164 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$26.5M, representing 1.04% of its reported portfolio and ranking #38 among its reported holdings. BRAIDWELL LP has disclosed ORKA holdings in 7 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)278.16K sh
Reported value held$26.47M
Portfolio Weight1.04%
First reportedQ3 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BRAIDWELL LP's ORKA position evolved

BRAIDWELL LP first disclosed a stake in ORKA in Q3 2024 at 515,726 shares (US$12.6M). The position peaked in Q4 2024 at 1,147,676 shares, worth US$27.1M. Across 7 filings, BRAIDWELL LP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 278,164 shares valued at US$26.5M. Notable position changes include a 123% increase in Q4 2024 (shares fell 47% over the following quarter), a 37% increase in Q1 2025 (shares rose 9% over the following quarter), a 94% trim in Q4 2025 (shares rose 62% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 515.73K $12.64M New
Q4 2024 1.15M $27.10M Add
Q1 2025 1.57M $16.13M Add
Q2 2025 1.52M $17.09M Reduce
Q3 2025 1.38M $26.58M Reduce
Q4 2025 84.80K $2.57M Reduce
Q2 2026 278.16K $26.47M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 98 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has BRAIDWELL LP held ORKA?

BRAIDWELL LP has disclosed ORKA holdings in 7 of the last 8 reported quarters, going back to Q3 2024.

What is BRAIDWELL LP's current position in ORKA?

As of Q2 2026, BRAIDWELL LP holds 278.16K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $26.47M, representing 1.04% of its reported portfolio and ranking #38.

Has BRAIDWELL LP been buying or selling ORKA?

In the latest 13F filing (Q2 2026), BRAIDWELL LP newly opened its position in ORKA. The position peaked in Q4 2024 at 1.15M shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 98 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.